| Date |
Research Question / Title |
Unique ID |
Research Team |
|
November 25, 2020
|
Are probiotics effective for prevention or therapy of respiratory tract infections in all ages?
|
EOC111201 RR
|
EOC
|
|
December 26, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v019 RR
|
Infectious Disease
|
|
December 17, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501 RR
|
Infectious Disease
|
|
April 6, 2021
|
How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals
|
CC210301 RR
|
Critical Care
|
|
January 12, 2022
|
In real world settings, what is the validity of Rapid Antigen Tests (RATs) in identifying SARS-CoV-2 and how well do they predict disease?
|
EOC211201 RR
|
EOC
|
|
May 22, 2020
|
In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation?
|
EOC052102 RR
|
EOC
|
|
June 30, 2022
|
Response to Long COVID: What are the programs or accommodations to current frameworks?
|
EOC220303 RR
|
EOC
|
|
June 20, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v002 RR
|
Epidemiology & Modelling
|
|
January 13, 2021
|
What are the outcomes of ECMO and COVID, particularly in small centers?
|
EOC011101 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 25, 2020
|
What frequency of repeat population screening will be required?
|
LAB042202 RR
|
Laboratory
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
|
July 27, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001 RR
|
EOC
|
|
April 1, 2020
|
What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments?
|
EOC040101 RR
|
EOC
|
|
December 22, 2021
|
What is the epidemiology of the Omicron variant and its impact on health care?
|
EOC211220 RR
|
EOC
|
|
December 20, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v019 RR
|
EOC
|
|
February 27, 2021
|
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
|
CC011101 RR
|
Critical Care
|
|
March 31, 2022
|
What is the incidence and duration of long COVID cases?
|
EPM210601v2 RR
|
Epidemiology & Modelling
|
|
April 27, 2020
|
What is the period of communicability of symptomatic SARS-CoV-2?
|
INF042401 RR
|
Infectious Disease
|
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR
|
EOC
|
